Concepedia

Beth Knapp‐Reed

BK

Statistics

Publications

6

Citations

324

H-Index

6

Active since

2001

Affiliations

GlaxoSmithKline (United States)(Current)

South College

University of Michigan

Beth Knapp‐Reed is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2001–2019

6

Publications

6

Access to Macrocyclic Endocyclic and Exocyclic Allylic Alcohols by Nickel-Catalyzed Reductive Cyclization of Ynals

Beth Knapp‐Reed, Gireesh M. Mahandru, John Montgomery · Journal of the American Chemical Society · 2005 · 106 citations

, , +13

Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain

William Roush, Jianming Cheng, Beth Knapp‐Reed et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 89 citations

, , +8

Total Synthesis of Aigialomycin D:  Surprising Chemoselectivity Dependence on Alkyne Structure in Nickel-Catalyzed Cyclizations

Christa C. Chrovian, Beth Knapp‐Reed, John Montgomery · Organic Letters · 2008 · 56 citations

, , +17

Tetrahydro-4-quinolinamines identified as novel P2Y1 receptor antagonists

Ángel I. Morales-Ramos, John S. Mecom, Terry J. Kiesow et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 33 citations · Full text

, , +9

Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors

Curt D. Haffner, Adam K. Charnley, Christopher Aquino et al. · ACS Medicinal Chemistry Letters · 2019 · 26 citations · Full text

, , +17

1–5 of 6